Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with ESPR: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
ESPR
Esperion Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
ESPR
Esperion Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
ESPR, dashed
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
ESPR
Esperion Therapeutics, Inc.
Change
3.19
▼
−0.16%
· post 3.20
Closed
Nov 6 '26
Mkt cap
$818.6M
Revenue
$80M
Q1 FY26
Revenue
$403M
FY25
vs
Compare
Closed
Nov 6 '26
LLY
ELI Lilly & Co
vs
ESPR
Esperion Therapeutics, Inc.
1,360.90
▼
−0.28%
post 1,358.90
Price
3.19
▼
−0.16%
post 3.20
$1.2T
Mkt cap
$818.6M
Q3 FY26
$24.4B
Revenue
$80M
Q1 FY26
FY25
$65.2B
Revenue
$403M
FY25
Change
Change
LLY
1,360.90
▼
−0.28%
vs
ESPR
3.19
▼
−0.16%
Closed
Nov 6 '26